|
WO2016082714A1
|
|
Method for preparing medicament of antioxidant-free injection solution with long-term stability
|
|
TW201613564A
|
|
Process for the preparation of sustained-release microparticles having a controllable release profile
|
|
CN102604854A
|
|
Novel lactic acid bacterium strains and application thereof to adjustment of immune reaction
|
|
WO2011076095A1
|
|
Methods and compositions related to reduced met phosphorylation by leukocyte cell-derived chemotaxin 2 in tumor cells
|
|
WO2011127629A1
|
|
Pharmaceutical product of diphosphonate injection and preparation method thereof
|
|
TW201136591A
|
|
A pharmaceutical product containing a diphosphonate solution for injection and preparation of the same
|
|
TW201130499A
|
|
Method for reducing side effects of colistin injection
|
|
WO2011075912A1
|
|
Pharmaceutical composition for treating parkinson's disease and preparation method thereof
|
|
TW201012473A
|
|
Composition of inhibiting pathological angiogenesis
|
|
CN101665822A
|
|
Biological marker combination and application thereof
|
|
KR20100113527A
|
|
Injection comprising docetaxel and its preparation
|
|
TW200904397A
|
|
Method and apparatus for washing and collection of particles
|
|
TW200824679A
|
|
Three-part injectable composition comprising docetaxel in a surface active agent and an additive to prevent gelling on dilution and diluent
|
|
US2007032438A1
|
|
Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions
|
|
US2006275504A1
|
|
Methods and compositions for augmenting cancer chemotherapeutic agents
|
|
CN1843346A
|
|
Pharmaceutical composition containing paclitaxel analog compound and its preparation method
|
|
TW200522940A
|
|
Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions
|
|
CN1795867A
|
|
Liposome of doxorubicin and prepration method and application
|
|
TW200616676A
|
|
Use and manufacturing process for liposomal doxorubicin pharmaceutical composition
|
|
CN1689585A
|
|
Arsenic-containing pharmaceutical composition for treating skin metastatic carcinoma combined with radiotherapy
|
